Deploying a safe and effective Lassa vaccine across 15 countries in West Africa could save nearly 3,300 lives over 10 years and avert up to $128m in societal costs, according to new research by modelling experts. The peer-reviewed study, published on August 28, 2024, in Nature Medicine, is titled “Health and Economic Impacts of Lassa
